{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:37:00Z","timestamp":1784191020186,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.vaccine.2009.10.104","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T07:39:57Z","timestamp":1257406797000},"page":"657-663","source":"Crossref","is-referenced-by-count":47,"title":["Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2\u201310 years of age"],"prefix":"10.1016","volume":"28","author":[{"given":"S.","family":"Black","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bedell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Karsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Dull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2009.10.104_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0889-8561(03)00092-4","article-title":"Meningococcal immunology","volume":"23","author":"Lepow","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.vaccine.2009.10.104_bib2","unstructured":"Centers for Disease Control and Prevention (CDC). Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2006. Available at: http:\/\/www.cdc.gov\/ncidod\/dbmd\/abcs\/survreports\/mening06.pdf; 2007 [accessed 01.05.08]."},{"issue":"17","key":"10.1016\/j.vaccine.2009.10.104_bib3","first-page":"462","article-title":"Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2\u201310 years with quadrivalent meningococcal conjugate vaccine (MCV4)","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.104_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jama.285.2.177","article-title":"Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec","volume":"285","author":"De Wals","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2009.10.104_bib5","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/IAI.73.5.2932-2939.2005","article-title":"Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age","volume":"73","author":"Al-Mazrou","year":"2005","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.10.104_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/INF.0b013e3180cc2c25","article-title":"Reconsideration of the use of meningococcal polysaccharide vaccine","volume":"26","author":"Granoff","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"19","key":"10.1016\/j.vaccine.2009.10.104_bib7","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2174\/138161207781039850","article-title":"Meningococcal vaccines","volume":"13","author":"Price","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.104_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/01.mop.0000193265.78506.7f","article-title":"Recent trends in meningococcal epidemiology and current vaccine recommendations","volume":"18","author":"Baltimore","year":"2006","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2009.10.104_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1574-6976.2006.00051.x","article-title":"Conquering the meningococcus","volume":"31","author":"Stephens","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2009.10.104_bib10","first-page":"13","article-title":"Meningococcal disease and college students. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"RR-7","key":"10.1016\/j.vaccine.2009.10.104_bib11","first-page":"1","article-title":"National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2009.10.104_bib12","first-page":"1265","article-title":"Notice to readers: recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2\u201310 years at increased risk for invasive meningococcal disease","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2009.10.104_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1568005014605964","article-title":"Vaccines against polysaccharide antigens","volume":"1","author":"Lesinski","year":"2001","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"9320","key":"10.1016\/j.vaccine.2009.10.104_bib14","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Reduced carriage of serogroup C meningococci in teenagers one year after the introduction of meningococcal C conjugate polysaccharide vaccine in the United Kingdom","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"7385","key":"10.1016\/j.vaccine.2009.10.104_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.104_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jama.2007.29-c","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2009.10.104_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/INF.0b013e31818a0237","article-title":"A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents","volume":"28","author":"Jackson","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2009.10.104_bib18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09016557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09016557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T09:59:11Z","timestamp":1544867951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09016557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0264410X09016557"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}